IMP3 as a Cytoplasmic Biomarker for Early Serous Tubal Carcinogenesis
Journal of Experimental and Clinical Cancer Research - United Kingdom
doi 10.1186/preaccept-1744854612129169
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2014
Authors
Publisher
Springer Nature